BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 12589138)

  • 1. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCC in living donor liver transplantation: can we expand the Milan criteria?
    Kwon CH; Kim DJ; Han YS; Park JB; Choi GS; Kim SJ; Joh JW; Lee SK
    Dig Dis; 2007; 25(4):313-9. PubMed ID: 17960066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
    Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
    Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
    Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
    Sugawara Y; Tamura S; Makuuchi M
    Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center.
    Jonas S; Mittler J; Pascher A; Schumacher G; Theruvath T; Benckert C; Rudolph B; Neuhaus P
    Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
    J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
    Malagó M; Sotiropoulos GC; Nadalin S; Valentin-Gamazo C; Paul A; Lang H; Radtke A; Saner F; Molmenti E; Beckebaum S; Gerken G; Frilling A; Broelsch CE
    Liver Transpl; 2006 Jun; 12(6):934-40. PubMed ID: 16528715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation.
    Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC
    Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
    Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
    Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on the outcome of patients with hepatocellular carcinoma registered for living donor liver transplantation: how long can they wait?
    Mizuno S; Yokoi H; Shiraki K; Usui M; Sakurai H; Tabata M; Sugimoto K; Takei Y; Yamakado K; Takeda K; Uemoto S; Isaji S
    Transplantation; 2010 Mar; 89(6):650-4. PubMed ID: 20048691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
    Takada Y; Ito T; Ueda M; Sakamoto S; Haga H; Maetani Y; Ogawa K; Ogura Y; Oike F; Egawa H; Uemoto S
    Dig Dis; 2007; 25(4):299-302. PubMed ID: 17960063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
    Lee HS
    Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for hepatocellular carcinoma: a single-center experience in Taiwan.
    Concejero A; Chen CL; Wang CC; Wang SH; Lin CC; Liu YW; Yang CH; Yong CC; Lin TS; Jawan B; Huang TL; Cheng YF; Eng HL
    Transplantation; 2008 Feb; 85(3):398-406. PubMed ID: 18322432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.